$CNNN
ConneXionONE Corp.

2024 Q2 Form 10-Q Financial Statement

#000168316824003595 Filed on May 17, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $34.33K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $56.33K $114.9K $34.33K
YoY Change 238.2% 234.82% 13.97%
Operating Profit -$56.33K -$114.9K -$34.33K
YoY Change 238.2% 234.82% 13.97%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change
Pretax Income -$56.33K -$114.9K -$34.33K
YoY Change 238.2% 234.82% 13.97%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$56.33K -$114.9K -$34.33K
YoY Change 238.2% 234.82% 239.2%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 71.85M shares 76.57M shares 71.85B shares
Diluted Shares Outstanding 75.37M shares 76.57M shares 71.85M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.710K
YoY Change
Cash & Equivalents $261.00 $3.352K $1.705K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables $0.00 $512.0K
Total Short-Term Assets $261.00 $3.352K $513.7K
YoY Change -99.94% -99.35%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $572.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $572.0K $572.0K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $261.00 $3.352K $513.7K
Total Long-Term Assets $572.0K $572.0K $0.00
Total Assets $572.3K $575.4K $513.7K
YoY Change 21.62% 12.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $88.25K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.442M $1.388M $905.3K
YoY Change 64.04% 53.36%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $1.003M $1.003M $1.003M
YoY Change 0.0% 0.0%
Total Long-Term Liabilities $1.003M $1.003M $1.003M
YoY Change 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.442M $1.388M $905.3K
Total Long-Term Liabilities $1.003M $1.003M $1.003M
Total Liabilities $2.444M $2.391M $1.908M
YoY Change 29.91% 25.32%
SHAREHOLDERS EQUITY
Retained Earnings -$75.46M -$75.41M -$73.97M
YoY Change 2.0% 1.95%
Common Stock $76.57K $76.57K $71.85K
YoY Change 6.57% 6.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.872M -$1.816M -$1.394M
YoY Change
Total Liabilities & Shareholders Equity $572.3K $575.4K $513.7K
YoY Change 21.62% 12.0%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$56.33K -$114.9K -$34.33K
YoY Change 238.2% 234.82% 239.2%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$116.5K -$34.33K
YoY Change 239.33% 28505.83%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$130.0K -$132.0K
YoY Change -1.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $249.1K $163.0K
YoY Change 52.83% 135733.33%
NET CHANGE
Cash From Operating Activities -$116.5K -$34.33K
Cash From Investing Activities -$130.0K -$132.0K
Cash From Financing Activities $249.1K $163.0K
Net Change In Cash $2.627K -$3.327K
YoY Change -178.96%
FREE CASH FLOW
Cash From Operating Activities -$116.5K -$34.33K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$116.5K -$34.33K
YoY Change 239.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
usd
CY2023Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
000-50075
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
CONNEXIONONE CORP.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NC
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
30-1252905
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
530 Lytton Ave 2nd Floor #2061
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Palo Alto
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94301
CY2024Q1 dei City Area Code
CityAreaCode
408
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
533-8155
CY2024Q1 dei Security12g Title
Security12gTitle
Common Stock, Par Value $0.001
CY2024Q1 dei Trading Symbol
TradingSymbol
CNNN
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
71850644 shares
CY2024Q1 us-gaap Cash
Cash
3352 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
3352 usd
CY2024Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
572000 usd
CY2024Q1 us-gaap Assets
Assets
575352 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
12921 usd
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
225888 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
26000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
0 usd
CY2024Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2029 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
0 usd
CY2024Q1 AFTC Due To Related Party
DueToRelatedParty
1121554 usd
CY2023Q4 AFTC Due To Related Party
DueToRelatedParty
872446 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1388392 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1140833 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2024Q1 us-gaap Liabilities
Liabilities
2391031 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2143472 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76571644 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76571644 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76571644 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76571644 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
76572 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
76572 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
73515021 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
73515021 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-75407272 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-75292340 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1815679 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1700747 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
575352 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
442725 usd
CY2024Q1 us-gaap Revenues
Revenues
0 usd
CY2023Q1 us-gaap Revenues
Revenues
0 usd
CY2024Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
53000 usd
CY2024Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
24500 usd
CY2023Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
18127 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
114932 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
34327 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-114932 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-34327 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-114932 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34327 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-114932 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-34327 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.002
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.002
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.000
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76571644 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76571644 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71850644 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71850644 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1359925 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-34327 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1394252 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1700747 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-114932 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1815679 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-114932 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-34327 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-29578 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
0 usd
CY2024Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
26000 usd
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
0 usd
CY2024Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
2029 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-116481 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34327 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
CY2024Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
130000 usd
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
132000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-130000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-132000 usd
CY2024Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
249108 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
163000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
249108 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
163000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2627 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3327 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
725 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5032 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3352 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1705 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_zFa3MxzCl5h4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Use of estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s significant estimates include income taxes provision and valuation allowance of deferred tax assets; the fair value of financial instruments; the carrying value and recoverability of long-lived assets; and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management regularly reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-75407272 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
665735 usd
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
665735 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76571644 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76571644 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76571644 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76571644 shares
CY2023Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
reverse stock split of a one-for-one thousand (1:1,000)
CY2024Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
75250085 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-003595-index-headers.html Edgar Link pending
0001683168-24-003595-index.html Edgar Link pending
0001683168-24-003595.txt Edgar Link pending
0001683168-24-003595-xbrl.zip Edgar Link pending
aftc-20240331.xsd Edgar Link pending
cnnn_ex3101.htm Edgar Link pending
cnnn_ex3102.htm Edgar Link pending
aftc-20240331_cal.xml Edgar Link unprocessable
aftc-20240331_def.xml Edgar Link unprocessable
aftc-20240331_pre.xml Edgar Link unprocessable
aftc-20240331_lab.xml Edgar Link unprocessable
cnnn_ex3201.htm Edgar Link pending
cnnn_ex3202.htm Edgar Link pending
cnnn_i10q-33124.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
cnnn_i10q-33124_htm.xml Edgar Link completed